Zullig, L. L., Rushing, C., Chino, F. L., Samsa, G., Altomare, I., Tulsky, J. A., … Zafar, Y. (2014). Can we identify patients at risk for discordance in preferred and actual role in cancer treatment decision making? In Journal of Clinical Oncology (Vol. 32, pp. 6615–6615). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2014.32.15_suppl.6615

Zullig, Leah L., Christel Rushing, Fumiko Ladd Chino, Greg Samsa, Ivy Altomare, James A. Tulsky, Peter A. Ubel, et al. “Can we identify patients at risk for discordance in preferred and actual role in cancer treatment decision making?” In Journal of Clinical Oncology, 32:6615–6615. American Society of Clinical Oncology (ASCO), 2014. https://doi.org/10.1200/jco.2014.32.15_suppl.6615.

Zullig LL, Rushing C, Chino FL, Samsa G, Altomare I, Tulsky JA, et al. Can we identify patients at risk for discordance in preferred and actual role in cancer treatment decision making? In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2014. p. 6615–6615.

Zullig, Leah L., et al. “Can we identify patients at risk for discordance in preferred and actual role in cancer treatment decision making?” Journal of Clinical Oncology, vol. 32, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2014, pp. 6615–6615. Crossref, doi:10.1200/jco.2014.32.15_suppl.6615.

Zullig LL, Rushing C, Chino FL, Samsa G, Altomare I, Tulsky JA, Ubel PA, Nicolla J, Abernethy AP, Peppercorn JM, Zafar Y. Can we identify patients at risk for discordance in preferred and actual role in cancer treatment decision making? Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2014. p. 6615–6615.